The importance of claudin-7 palmitoylation on membrane subdomain localization and metastasis-promoting activities by Heiler, Sarah et al.
RESEARCH Open Access
The importance of claudin-7 palmitoylation
on membrane subdomain localization and
metastasis-promoting activities
Sarah Heiler, Wei Mu, Margot Zöller* and Florian Thuma*
Abstract
Background: Claudin-7 (cld7), a tight junction (TJ) component, is also found basolaterally and in the cytoplasm.
Basolaterally located cld7 is enriched in glycolipid-enriched membrane domains (GEM), where it associates with
EpCAM (EpC). The conditions driving cld7 out of TJ into GEM, which is associated with a striking change in function,
were not defined. Thus, we asked whether cld7 serines or palmitoylation affect cld7 location and protein,
particularly EpCAM, associations.
Results: HEK cells were transfected with EpCAM and wild type cld7 or cld7, where serine phopsphorylation or the
palmitoylation sites (AA184, AA186) (cld7mPalm) were mutated. Exchange of individual serine phosphorylation sites
did not significantly affect the GEM localization and the EpCAM association. Instead, cld7mPalm was poorly recruited
into GEM. This has consequences on migration and invasiveness as palmitoylated cld7 facilitates integrin and
EpCAM recruitment, associates with cytoskeletal linker proteins and cooperates with MMP14, CD147 and TACE,
which support motility, matrix degradation and EpCAM cleavage. On the other hand, only cld7mPalm associates with
TJ proteins.
Conclusion: Cld7 palmitoylation prohibits TJ integration and fosters GEM recruitment. Via associated molecules,
palmitoylated cld7 supports motility and invasion.
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Introduction
Claudins (cld), a family of closely related four-pass mole-
cules, are essential components of tight junctions (TJ) in
the apical region of epithelial cells. TJ, which include
JAM and occludins, regulate paracellular permeability
and epithelial cell polarity [1-4]. As tumor cell dissemin-
ation requires loss of cell-cell adhesion, it was expected
that claudins be downregulated in cancer. This however
was not consistently observed [3,5-7]. Fittingly, claudins,
most frequently cld7, also are recovered on the lateral or
basal surface [6,8-10]. However, functional activities of
claudins out of TJ are poorly defined [5].
Claudins have two palmitoylation sites towards the
inner membrane site of the second and forth transmem-
brane domain [11,12]. As described for G-protein coupled
receptors and tetraspanins [13-15], palmitoylation pro-
motes the recruitment into glycolipid-enriched membrane
microdomains (GEM) [16,17], which gather signal trans-
duction [16,18,19] and cytoskeleton anchoring molecules
[20]. Palmitoylation also promotes internalization and
degradation or integration into multivesicular bodies and
exosome delivery [21-24]. Claudins also have several phos-
phorylation sites [25,26]. Cld phosphorylation can prohibit
integration into TJ [27], but distinct claudins may respond
differently [28,29].
Claudins interact between themselves, additional TJ
components and TJ-independent membrane molecules.
CD9 and CD81 associate with cld1, the latter being
essential for hepatitis C virus infection [30-32]. The
interaction of EphrinB1 and EphrinA2 with cld4 affects
barrier functions and increases leakiness [33,34]. We
described that cld7 directly associated with EpCAM
(EpC) in the transmembrane region [35]. EpC-cld7 co-
localization is seen in colon, pancreatic and anaplastic
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thyroid carcinoma [36,37]. Pursuing in a rat pancreatic
adenocarcinoma the impact of cld7 on EpC activity and
vice versa revealed that cld7 recruits EpC into GEM,
where both molecules associate with the tetraspanin
Tspan8 and additional transmembrane molecules. These
latter associations likely are not based on direct protein-
protein interactions [36,37]. A cld7kd and an EpCkd re-
vealed a striking reduction in metastasis formation,
where cld7 supports tumorigenic features of EpC by
provoking EpC cleavage and thereby the cotranscription
factor activity of its intracellular domain (EpIC) [38,39].
Cld7 also associates with EpC in hepatocyte progenitors
[40]. In congenital tufting enteropathy, characterized by
a deletion of EpC exon 4, the loss of co-localization with
cld7 is lethal [41]. Notably, an EpCko is associated with
intestine destruction-promoted death within one week
after birth, due to the missing association of EpC with
cld7, which is accompanied by reduced cld7 expression
[42]. The pathology resembles that of cld7ko mice,
which also die within 1 week after birth, due to altered
barrier functions and inflammation-promoted gut destruc-
tion. The authors discuss the importance of a missing
association with integrins and a striking up-regulation of
MMP3 [43].
These findings strengthening our hypothesis on TJ-
independent functions and cooperations of cld7 under
(patho)physiological conditions [44-47], we aimed to
elaborate the molecular mechanism prohibiting cld7
integration into TJ. As a model we choose HEK cells,
which express cld7 at a very low level. HEK cells were
transfected with serine- and palmitoylation-site-mutated
cld7. We focused on cld7 palmitoylation, as palmitoylation
is of critical importance for GEM localization, complex
formation and recruitment of cytoskeletal linker and cyto-
solic signaling molecules [48-51]. To control for activities
that depend on the cooperation with EpC, HEK cells were
concomitantly transfected with EpC cDNA or a point mu-
tated EpC cDNA that does not associate with cld7. Cld7
palmitoylation prohibits integration into the TJ protein
complex. Instead, palmitoylated cld7 is preferentially re-
cruited into GEM, where it associates with integrins and
cytoskeletal linker proteins, which promote motility.
Motility is additionally strengthened by cleavage of pal-
mitoylated cld7-associated EpC, the co-transcription
factor EpIC (EpC intracellular domain) supporting
mesenchymal gene expression. Finally, palmitoylated
cld7 associates with proteases, which strongly affects
invasiveness.
Results
The activity of cld7 outside of TJ is still disputed. We
described recovery of cld7 in GEM, where it associates
with EpC, tetraspanins and integrins, which supports
motility and possibly the epithelial mesenchymal
transition (36,52). The molecular basis for driving cld7
out of TJ into GEM as well as the GEM-location-
dependent associations remained to be explored. We
approached these questions by transfecting HEK cells
with cld7, where serine phosphorylation sites (mS) and
the palmitoylation site at the C-terminal cytoplasmic tail
(mPalm) were mutated. The impact particularly on asso-
ciating EpC was controlled by co-transfecting HEK cells
with EpC, exchanging AA279 and AA282 by isoleucin
(mAG), which prohibits cld7 binding (35,36).
Claudin7 palmitoylation affects membrane subdomain
localization and the association with EpC
We first evaluated the impact of serine phosphorylation
on cld7 recruitment into GEM and on the association
with EpC. HEK-EpC cells were transfected with seven
different serine phosphorylation site point-mutated cld7
constructs (Additional file 1). WB showed comparable
cld7 expression levels in non-mutated/mutated cld7 trans-
fected HEK-EpC cells (Additional file 2a). The exchange
of cld7 serines did not affect co-immunoprecipitation of
EpC with cld7 (Additional file 2b). WB of sucrose density
gradient fractions revealed partial recovery of cld7 in
GEM. In the absence of cld7, EpC is mostly recovered
in heavy fractions, but becomes partially recruited into
light fractions in the presence of cld7. The distribution
of EpC in light sucrose density fractions corresponded
to the distribution of cld7. Recovery of EpC in GEM
fractions varied between 55%-72% and of cld7 between
57%-73%. Thus, single serine mutations did not
strongly affect or abolish GEM localization of cld7 and
the recruitment of EpC into GEM (Additional file 2c).
Co-immunoprecipitation confirmed that anti-EpC pre-
cipitates cld7 and anti-cld7 precipitates EpC. Irrespect-
ive of cld7 serine mutations, ~60%-70% of EpC-cld7
complexes are recovered in GEM. This is demon-
strated for cld7mS33, cld7mS69, cld7mS87 and cld7mS204
(Additional file 2d), and also accounted for cld7mS172,
cld7mS206 and cld7mS207 (data not shown).
We concluded that cld7 is preferentially located in
GEM and recruits EpC into GEM. Single serine phosphor-
ylation of cld7 does not considerably contribute to the
EpC-cld7 association or to the membrane distribution of
cld7 and the EpC-cld7 complex.
We proceeded evaluating the impact of cld7 palmitoy-
lation, a modification known to support protein anchor-
ing in GEM [16,17]. HEK-EpC cells were transfected
with cld7 carrying a mutation of the palmitoylation site
at the C-terminal tail (HEK-EpC-cld7mPalm). To control,
in addition, whether only cld7-associated EpC becomes
recruited into GEM, HEK-cld7 cells were transfected
with EpC cDNA mutated at AA279 and AA282 (HEK-
EpCmAG-cld7), which account for the EpC-cld7 associ-
ation [36]. Flow cytometry and WB confirmed comparable
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EpC / EpCmAG and cld7 / cld7mPalm expression in trans-
fected HEK cells (Figure 1a).
The efficacy of inhibiting cld7 palmitoylation by the
exchange of cysteine AA184 and AA186 was controlled
by immunoprecipitation and acyl-biotin exchange in
HEK-EpC-cld7 and HEK-EpC-cld7mPalm lysates in the
absence or presence of the palmitoylation inhibitor 2-BP.
No palmitoylation signal was detected in the presence of
2-BP, but a strong signal was seen in HEK-EpC-cld7
lysates. A very faint band remained in HEK-EpC-
cld7mPalm. Stripping the gel and blotting with anti-cld7
confirmed equal loading. From there we conclude that
mutating AA184 and AA186 sufficed to prevent palmitoy-
lation and also that the C-terminal palmitoylation site
mostly accounts for cld7 palmitoylation (Figure 1b). We
next evaluated the impact of mutating the cld7
Figure 1 Claudin-7 palmitoylation: Impact on membrane subdomain localization and protein association (a-e) HEK cells were transfected with EpC
and/or wt cld7 or EpC with a mutation of (mAG) in the transmembrane region or with cld7, with a palmitoylation site mutation. (a) WB of non-transfected
and transfected HEK with anti-EpC, anti-cld7 and anti-actin (loading control); an example of flow cytometry analysis of EpC and cld7 in transfected HEK cells:
single fluorescence overlays of negative controls and anti-EpC or anti-cld7 staining; (b) HEK-EpC-cld7 and HEK-EpCmAG-cld7 were lysed in the presence of
N-ethylmaleimide to irreversibly block unmodified thiol groups. After incubation with HAM buffer for unmasking palmitoylated cysteine thiol groups,
samples where incubated in biotin-BMCC for selective labeling palmitoylated cysteines. Samples were blotted with streptavidin-HRP and after stripping
with anti-cld7. (c) WB of sucrose density fractions of untreated and 2-BP-treated HEK-EpC-cld7 and HEK-EpC-cld7mPalm with anti-cld7 and anti-EpC; (d) IP
of HEK-EpC-cld7, HEK-EpCmAG-cld7 and HEK-EpC-cld7mPalm lysates with control IgG, anti-EpC and anti-cld7 and WB with anti-EpC and
anti-cld7; (e) WB of non-mutated and mutated EpC and cld7 in light and heavy density fractions after density gradient centrifugation;
constitutively GEM-located CD81 served as control; relative protein band intensity and the protein ratio in light to heavy fractions is
indicated; (f) immunoprecipitation with control IgG, anti-EpC and anti-cld7 of lysates of non-mutated and mutated EpC and cld7 in light
and heavy density fractions and WB with anti-EpC and anti-cld7; (g-i) SDS-PAGE, Coomassie-blue staining, in vitro kinase assay of whole cell
and membrane lysates and WB with anti-p-tyrosine of anti-cld7 immunoprecipitates of HEK-EpC-cld7, HEK-EpCmAG-cld7 and HEK-EpC-cld7mPalm
lysates. Co-transfection of HEK-EpC with cld7 shifts EpC into GEM. Instead, recovery of EpCmAG in GEM and co-immunoprecipitation with cld7 is
strikingly reduced. Palmitoylation site mutated cld7 is hardly recovered in GEM and only few, mostly non-palmitoylated molecules associate
with cld7mPalm.
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palmitoylation site on the recruitment into GEM and the
association with EpC using the palmitoylation inhibitor
(2-BP) [53]. WB of 2-BP-treated HEK-EpC-cld7 cells
showed a striking redistribution of cld7 with >90% recov-
ery in the heavy fraction. The same accounted for EpC.
On the contrary, cld7 was not recovered in GEM and 2-
BP treatment had no impact on the cld7 GEM distribution
in HEK-EpC-cld7mPalm (Figure 1c). Thus, a considerable
part of cld7 is palmitoylated and palmitoylation accounts
for GEM recruitment. The finding also strengthens our
interpretation that cld7 recruits EpC towards GEM.
We proceeded with HEK-EpC-cld7mPalm and HEK-
EpCmAG-cld7 cells, where selectively cld7 palmitoyla-
tion and the cld7-EpC association should be distorted.
Co-immunoprecipitation of EpC and cld7 was strikingly
reduced in HEK-EpCmAG-cld7 and HEK-EpC-cld7mPalm
lysates (Figure 1d). In HEK-EpCmAG, EpC was recovered
in heavy sucrose gradient fractions, but cld7 remained
enriched in GEM. Instead, cld7mPalm partly shifted to-
wards the dense fractions. Enrichment of the constitu-
tively GEM-located tetraspanin CD81 in fraction 2–5
was independent of cld7 palmitoylation (Figure 1e).
Furthermore, EpC was not detected in light and was
poorly recovered in heavy density fractions in anti-cld7
immunoprecipitates of HEK-EpC-cld7mPalm lysates. In
HEK-EpCmAG-cld7 lysates, anti-EpC weakly co-
imunoprecipitated cld7 only in heavy density fractions,
but cld7 was still recovered in light density fractions of
anti-cld7 precipitates (Figure 1f). Furthermore, cld7mPalm
and EpCmAG severely influenced the phosphorylation sta-
tus of associated molecules. First to note, SDS-PAGE and
Coomassie blue staining of anti-cld7 precipitates revealed
a reduction of co-immunoprecipitating molecules in
EpCmAG and more pronounced cld7mPalm lysates, indi-
cating that EpC- and cld7-associating molecules are
partly overlapping (Figure 1g). Notably, a kinase assay
revealed phosphorylation of a considerable number of
molecules co-immunoprecipitating with cld7 in HEK-
EpC-cld7, but not in HEK-EpCmAG-cld7 or HEK-EpC-
cld7mPalm lysates. The finding was confirmed in a kinase
assay with lysates of the membrane fraction. In addition,
recovery of ~15 kDa and ~11 kDa phosphorylated pro-
teins, which abundantly immunoprecipitated in whole cell
lysates, was poor in the membrane fraction IP. This could
be indicative for loosely attached cytosolic proteins
(Figure 1h). These molecules and a ~60 kDa protein are
exclusively serine or threonine phosphorylated as they
were not recovered in an anti-p-tyrosine blot (Figure 1i).
We conclude that mostly serine/threonine phosphorylated
proteins associated exclusively with palmitoylated cld7.
MALDI-TOF analysis of lower molecular weight
proteins of HEK-EpC-cld7, HEK-EpCmAG-cld7 and
HEK-EpC-cld7mPalm lysates, which co-immunoprecipitated
with cld7, confirmed that a considerable number of
proteins co-immunoprecipitated with cld7 only in
HEK-EpC-cld7, but not in HEK-EpCmAG-cld7 and,
more pronounced in HEK-EpC-cld7mPalm lysates. Due
to very mild lysis condition, many co-immunoprecipitating
molecules may be loosely attached and be part of larger
protein complexes. Notably, the majority of molecules co-
immunoprecipitating with cld7 in HEK-EpC-cld7, HEK-
EpCmAG-cld7 and HEK-EpC-cld7mPalm lysates is engaged in
metabolism and ion transport. Instead, an unexpectedly
high number of molecules co-immunoprecipitating with
cld7 only in HEK-EpC-cld7 lysates is engaged in vesicle
transport (Additional file 3).
Briefly, (i) cld7 palmitoylation is essential for stabilization
in GEM and for the association with EpC and other trans-
membrane and membrane-associated molecules; (ii) the
association with palmitoylation-competent cld7 severely
affects the activation state of co-immunoprecipitating
molecules; (iii) molecules associated with vesicle traffic
preferentially associated with palmitoylation-competent
cld7, which strengthens our hypothesis of distinct func-
tions of palmitoylated versus non-palmitoylated cld7. The
selectivity of palmitoylated cld7 membrane subdomain
localization and protein associations offered the possibility
to control for palmitoylation-dependent cld7 activities.
Cld7 palmitoylation interferes with cell-cell adhesion
Formation of TJ is one of the central activities of clds
[54]. As cld7 is also recovered outside of TJ and palmi-
toylation strongly affects cld7 location [35,54,55], we
first asked, whether palmitoylation directly affects cld7
integration into TJ.
HEK cells express cld3 at a high, ZO-1 and cld4 at an
intermediate and cld7 at a very low level (Figure 2a).
Cld7 poorly colocalizes with cld3 or ZO-1. However,
there is a tendency towards more pronounced colocali-
zation of palmitoylation-deficient cld7 with cld3 and
ZO-1. Distinct to cld7, cld4 readily colocalizes with ZO-1
(Figure 2b). Co-immunoprecipitation confirmed that only
cld7mPalm, but not palmitoylation-competent cld7 associ-
ates with cld3, cld4 and ZO-1. Instead, anti-ZO-1 precipi-
tates cld3 and cld4, but only cld7mPalm (Figure 2c). Thus,
only non-palmitoylated / palmitoylation-deficient cld7
may contribute to TJ formation.
Similar to cld7, EpC is a homophilic cell-cell adhesion
molecule [56]. To control for a potential impact of the
association with cld7, CFSE-labeled HEK-EpC-cld7,
HEK-EpCmAG-cld7 and HEK-EpC-cld7mPalm cells were
seeded on a monolayer of HEK-EpC-cld7, HEK-EpCmAG-
cld7 or HEK-EpC-cld7mPalm cells. Slightly more HEK-
EpCmAG-cld7 and HEK-EpC-cld7mPalm than HEK-EpC-cld7
cells adhered to the HEK-EpC-cld7 monolayer (Figure 3a).
Increased cell-cell adhesion of HEK-EpCmAG-cld7 was due
to EpC binding, as it was inhibited by anti-EpC (Figure 3b).
This finding supports the interpretation that GEM-located
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cld7 also interferes with homophilic EpC tetramer cell-cell
adhesion.
Cld7 additionally could hamper EpC-mediated cell-cell
adhesion by supporting TACE-dependent EpC cleavage
[39]. In fact, the TACE inhibitor TAPI strengthened cell-
cell adhesion (Figure 3b). TAPI abolished EpEx gener-
ation and EpEx recovery was reduced in the supernatant
of HEK-EpCmAG-cld7 and HEK-EpC-cld7mPalm cells
(Figure 3c). Confocal microscopy showed proximity of
TACE to EpC only in HEK-EpC-cld7 cells, but very
weak colocalization in HEK-EpCmAG-cld7 and HEK-
EpC-cld7mPalm cells. Cld7 also colocalized with TACE
in HEK-EpCmAG-cld7, but poorly in HEK-EpC-
cld7mPalm cells (Figure 3d). WB confirmed partial re-
covery of TACE in GEM of HEK-EpC-cld7 and HEK-
EpCmAG-cld7, but not HEK-EpC-cld7mPalm cells (Fig-
ure 3e). Finally, anti-TACE co-immunoprecipitates EpC
and cld7 in light sucrose density gradient fractions of
HEK-EpC-cld7, but not HEK-EpC cld7mPalm lysates
(Figure 3f ).
Taken together, cld7 palmitoylation prohibits engage-
ment in TJ and interferes with EpC homophilic cell-cell
adhesion. Cld7-associated TACE, which supports EpC
cleavage, additionally affected EpCAM cell-cell adhesion.
Claudin-7 palmitoylation promotes cell motility
Based on the finding that palmitoylation hampers cell-
cell adhesion, we speculated that it might foster motility.
The impact of cld7 palmitoylation on motility was evalu-
ated in an in vitro wound healing assay, by transwell mi-
gration and by videomicroscopy. Wound closure after
scratching a cell monolayer is accelerated in HEK-cld7
and HEK-EpC-cld7 compared to HEK and HEK-EpC
cells. Motility of HEK-EpCmAG-cld7 is comparable to
that of HEK-EpC-cld7, but motility of HEK-EpC-
cld7mPalm is reduced (Figure 4a). Transwell migration
(Figure 4b) and videomicroscopy (Figure 4c) confirmed
that HEK-cld7 and HEK-EpC-cld7 cells migrate signifi-
cantly faster than HEK and HEK-EpC cells and that
migration of HEK-EpC-cld7mPalm is reduced. These
Figure 2 Claudin7 palmitoylation and TJ formation (a) Flow cytometry analysis of claudin and ZO-1 expression in HEK cells; the mean fluorescence
index (% stained cells x mean intensity of staining ± SD; three assays) and representative examples are shown; (b) colocalization of cld7 with cld3 and
ZO-1 and of cld4 with ZO-1 (scale bar: 10 μm); (c) immunoprecipitation with control IgG, anti-cld7 and anti-ZO-1 and co-immunoprecipitation of cld7, EpC,
cld3, cld4 and ZO-1 in HEK-EpC-cld7, HEK-EpCmAG-cld7 and HEK-EpC-cld7mPalm lysates. Palmitoylated cld7 poorly colocalizes and co-immunoprecipitates
with TJ proteins.
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findings pointed towards palmitoylated cld7 actively pro-
moting motility, but also pointed towards a contribution
of EpC. The latter suggestion derives from the observa-
tion that HEK-EpCmAG-cld7 cells migrate slower than
HEK-EpC-cld7 cells.
Phalloidin staining of HEK cells uncovered a disorga-
nized cytoskeleton [57], but a striking enrichment in
barbs and strong submembrane bundles in HEK-cld7
and HEK-EpC-cld7 cells. Actin is less efficiently orga-
nized in HEK-EpCmAG-cld7 and HEK-EpC-cld7mPalm
cells (Figure 5a).
HEK cells express the α5β1 and very weakly the α6β4
integrin; they highly express CD166. Expression remains
unchanged in cld7 transfected cells. Furthermore, (p)-ezrin,
(p)-src, (p)-FAK and paxillin expression is not significantly
reduced in HEK-EpCmAG-cld7 and HEK-EpC-cld7mPalm
cells (Figure 5b, 5c). Despite unaltered expression, coloca-
lization of cld7 with integrins, but not with CD166, is
weakened in HEK-EpC-cld7mPalm and HEK-EpCmAG-cld7
(Figure 5d) and colocalization with ezrin and src is weak-
ened in HEK-EpC-cld7mPalm cells (Figure 6a). These find-
ings suggested that the cld7-initiated organization of the
Figure 3 Claudin7 palmitoylation and homophilic EpC cell-cell adhesion (a,b) CFSE-labeled transfected HEK cells were seeded on a monolayer of
HEK-EpC-cld7 cells with/without mutations of EpC or cld7. Where indicated, cells were cultured in the presence of anti-EpC (10 μg / ml) or TAPI
(50 μM / ml). The percent of adherent cells (mean ± SD; triplicates) is shown; significant differences between HEK-EpC-cld7 and HEK-EpCmAG-cld7
or HEK-EpC-cld7mPam: *, significant differences by anti-EpC: s; significant differences in the presence of TAPI: +. (c) Supernatant of confluent PMA
stimulated HEK-EpC-cld7, HEK-EpCmAG-cld7 and HEK-EpC-cld7mPalm cells was collected after 48 h of culture in the absence of FCS. Where indicated
cultures contained 50 μM / ml TAPI. Cell debris- and vesicle-depleted supernatant were adjusted to 100 μg / ml protein, were separated by
SDS-PAGE and after transfer were blotted with anti-EpC or ELISA plates were coated with the concentrated supernatant. After blocking, EpEx was
detected by anti-EpC binding. The OD at 595 nm (mean ± SD; triplicates) is shown; significant differences between HEK-EpC-cld7 and HEK-EpCmAG-cld7
or HEK-EpC-cld7mPalm: *, significant differences in the presence of TAPI: +. (d) Confocal microscopy of HEK, HEK-EpC, HEK-cld7, HEK-EpC-cld7,
HEK-EpCmAG-cld7 and HEK-EpC-cld7mPalm cells stained with anti-TACE and anti-EpC or anti-cld7. Green and red fluorescence and overlays of
red and green fluorescence are shown (scale bar: 10 μm). (e) Lysates of cells as above were separated by sucrose gradient centrifugation and
blotted with anti-TACE. (f) Lysates of the cells as above were precipitated with anti-TACE. After sucrose gradient centrifugation of the precipitates,
SDS-PAGE and transfer, membranes were blotted with anti-EpC, anti-cld7 and anti-TACE. Palmitoylated cld7 interferes with homophilic EpC adhesion,
which is partly due to the association of palmitoylated cld7 with TACE in GEM, which promotes EpEx cleavage.
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actin cytoskeleton (Figure 5a) is supported by ezrin, which
associates with palmitoylated cld7. In fact, ezrin poorly
associates with cld7mPalm and the association is nearly
abolished in the presence of a palmitoylation inhibitor
(Figure 6b). As actin reorganization is not completely
abolished in HEK-EpC-cld7mPalm cells, we speculated that
the cld7-ezrin association is not a direct protein inter-
action, but is promoted by cld7-associated partner mole-
cules. Besides with EpC, cld7 co-immunoprecipitates with
CD104, CD49e and CD166. Co-immunoprecipitation of
cld7 with CD49e and CD166 is very weak in HEK-
EpCmAG-cld7 and HEK-EpC-cld7mPalm lysates. In anti-
ezrin precipitates, recovery of EpC and cld7 is most
strongly affected in HEK-EpC-cld7mPalm and in anti-
CD49e and CD166 precipitates ezrin recovery is strongly
reduced in HEK-EpC-cld7mPalm (Figure 6c). These find-
ings indicate that palmitoylated cld7 supports integrin
activation. Activated integrins, in turn, associate via
phosphorylated ezrin with the actin cytoskeleton. Support-
ing the mediator role of palmitoylated cld7, src did not
co-immunoprecipitate with cld7 in HEK-EpC-cld7mPalm
lysates. Co-immunoprecipitation of FAK and paxillin was
not abolished, though reduced (Figure 6d). Thus, GEM-
located palmitoylated cld7 supports motility via the associ-
ation with ezrin and integrins, where integrin activation
contributes to increased motility.
Videomicroscopy pointed towards an additional con-
tribution of EpC to cld7-promoted motility (Figure 4c).
Cld7 contributes via the association with TACE to EpC
cleavage (Figure 3f ). As presenilin2 also resides in GEM
[58], we speculated that the association of EpC with cld7
might facilitate the release of EpIC. Staining with anti-cld7
and anti-EpIC revealed, expectedly, stronger colocalization
in the membrane of HEK-EpC-cld7 than HEK-EpC-
cld7mPalm cells, but also more pronounced recovery of free
EpIC in the cytoplasm. WB confirmed higher EpIC
Figure 4 Palmitoylated claudin7 promotes cell motility (a) Cells were seeded in FN-coated 24-well plates. Subconfluent cultures were scratched
with a pipette tip. Wound healing was followed by light microscopy. Examples and mean ± SD (triplicates) of wound closure are shown (scale
bar: 250 μm). (b) Cells suspended in RPMI / 1%BSA were seeded in the upper chamber of a Boyden chamber. The lower chamber contained
RPMI/20%FCS. After 16 h of incubation, cells at the lower membrane site were stained with crystal violet and OD 595 nm was determined
after lysis; mean ± SD of triplicates. (c) Cells were seeded on BSA-coated 24-well plates. Cell migration was followed for 12 h by videomicroscopy
taking pictures every 20 min; examples and the mean ± SD migration of 20 individual cells. (a-c) Significant differences between HEK, HEK-EpC,
HEK-EpC-cld7, HEK-EpC-cld7, HEK-EpCmAG-cld7 and HEK-EpC-cld7mPalm: *. Palmitoylated cld7 significantly strengthens HEK cell migration.
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recovery in HEK-EpC-cld7 than in HEK-EpC lysates. On the
other hand, EpIC was not detected in HEK-EpCmAG-cld7
and very weakly in HEK-EpC-cld7mPalm lysates (Figure 7a).
This implies that palmitoylated cld7-associated, GEM-
located EpC becomes particularly susceptible for prese-
nilin2. Nonetheless, presenilin2 co-immunoprecipitated
also with cld7mPalm, but exclusively in heavy fractions
(Figure 7b). Flow cytometry and WB confirmed unaltered
β-catenin expression in HEK-cld7, −EpC-cld7, −EpCmAG-
cld7 and -EpC-cld7mPalm cells and only a minor reduction
of presenilin2 in HEK-EpC-cld7mPalm cells (Figure 7c,
Additional file 4). Increased EpIC recovery in HEK-EpC-
cld7 cells was accompanied by slightly upregulated expres-
sion of vimentin, fibroblast growth factor (FGF), TGFβ
and N-cadherin. Upregulated N-cadherin expression did
not correlate with the generation of EpIC (HEK-EpC-cld7)
and downregulation of E-cadherin in HEK-EpC-cld7 cells
did not reach the level of statistical significance. Colocali-
zation of FGF, N-cadherin and vimentin is less pro-
nounced in HEK-EpC-cld7mPalm than HEK-EpC-cld7 cells
(Figure 7d, 7e), where palmitoylated cld7 supports EpIC
generation. The pronounced EpIC generation by palmi-
toylated cld7 might strengthen expression of mesenchy-
mal markers associated with a migratory phenotype.
However, our findings point towards an engagement of
additional components.
Taken together, cld7 promotes motility, which is partly
due to the association of palmitoylated cld7 with p-ezrin
and is supported by the association with integrins and
CD166. Palmitoylated cld7 promotes the generation of
EpIC, which contributes to motility by forcing mesen-
chymal protein expression.
Palmitoylated claudin-7 supports invasiveness
Cld7 repressing MMP3 [43], we wondered whether
HEK-cld7 cells gain in motility, but concomitantly loose
invasiveness.
HEK-cld7, HEK-EpC-cld7 and HEK-EpCmAG-cld7 cells
show pronounced matrigel invasion. Invasion of HEK-
EpC-cld7mPalm resembles that of HEK, i.e. is strongly
Figure 5 Cooperativity of palmitoylated claudin-7 with integrins (a) Confocal microscopy of F-actin staining and co-localization (overlay of green
and red fluorescence) with EpC and cld7 (scale bar: 10 μm). (b, c) Flow cytometry analysis of adhesion molecules and cytoskeletal linker proteins
in untransfected and transfected HEK cells; the mean fluorescence index (% stained cells x mean intensity of staining ± SD; three assays) and
representative examples are shown. (d) Cld7 co-localization with integrins and CD166 (confocal microscopy, green and red fluorescence and
overlays, scale bar: 10 μm). Cld7 expression allows for actin filament formation in HEK cells, which likely is supported by the association of cld7
with integrins. Cld7 palmitoylation also facilitates colocalization with CD166.
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reduced (Figure 8a). This expectation-opposing finding
prompted a search for MMP activity of untransfected and
transfected HEK cells. HEK cells express MMP2, MMP3,
MMP7, MMP9 and MMP13 at low, MMP14 at intermedi-
ate and CD147 at high level. MMP3, MMP7 and MMP9
expression is slightly reduced in cld7 expressing cells, but
the reduction does not essentially correlate with cld7 pal-
mitoylation (Figure 8b). Notably, cld7 does not colo-
calize with MMP3 and only palmitoylation-competent
cld7 weakly colocalizes with MMP14 (Figure 8c).
As changes in protease expression could not explain
increased invasiveness of HEK-EpC-cld7 cells, we specu-
lated on pronounced protease activation, possibly due to
the weak association of cld7 with MMP14. Zymography
revealed low MMP2 and MMP9 activity in HEK and
HEK-EpC cells, strongly increased activity in HEK-EpC-
cld7, but reduced activity in HEK-EpC-cld7mPalm cells
(Figure 9a). Though this finding fits reduced invasive-
ness of HEK-EpC-cld7mPalm, we wondered, whether pal-
mitoylated cld7 recruits CD147 (EMMPRIN) into GEM,
which could contribute to MMP stabilization. Indeed,
anti-CD147 efficiently inhibits matrigel invasion of
HEK-cld7, HEK-EpC-cld7 and HEK-EpCmAG-cld7 cells
(Figure 9b). Furthermore, CD147 colocalizes and co-
immunoprecipitates with cld7 in HEK-EpC-cld7 and
HEK-EpCmAG-cld7, but hardly in HEK-EpC-cld7mPalm
cells (Figure 9c, 9d, Additional file 3).
Though slightly affecting MMP3, MMP7 and MMP9
expression, cld7 fosters invasiveness via GEM-located
MMP14, which holds MMP2 and MMP9 in membrane
proximity. High CD147 expression likely promotes MMP
induction.
In brief, palmitoylated cld7 poorly associates with TJ
proteins. Instead, it is recruited into GEM, where it asso-
ciates with the cytoskeleton, integrins, and integrin sig-
naling partners, EpC and proteases. It promotes integrin
and protease activation and EpC cleavage, supporting
motility and invasion.
Discussion
Functional activities of claudins outside TJ are not well
explored. This includes cld7, highly expressed in the
Figure 6 Cooperativity of palmitoylated claudin-7 with the cytoskeleton (a) Cld7 co-localization with ezrin and src (confocal microscopy, green and
red fluorescence and overlays, scale bar: 10 μm) and (b) control IgG and cld7 co-immunoprecipitation with ezrin and p-ezrin in the absence or
presence of a palmitoylation inhibitor (2-BP, 15 μM) and (c) control IgG, cld7 and ezrin co-immunoprecipitation with cld7, EpC, CD104 and ezrin;
EpC, CD49d and CD166 co-immunoprecipitation with cld7, ezrin and EpC; (d) cld7 co-immunoprecipitation with src, FAK, paxillin and cld7 in
transfected HEK cells. Cld7 associates with the cytoskeletal linker protein ezrin. Cld7 palmitoylation facilitates ezrin binding (and F-actin
formation). This also accounts for the association with CD49e, CD166, src, FAK and paxillin. Recruitment of the latter two towards cld7 does not
essentially depend on, but becomes strengthened by cld7 palmitoylation.
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upper gastrointestinal tract and the liver, where it is not
exclusively found in TJ [6,8,9,28,29,59]. Instead, cld7
associates in hepatocyte progenitors and gastrointes-
tinal tumors with EpC that is not a TJ component
[36,40,59,60]. Taking the importance of cld7 in organo-
genesis, cld7ko mice dying few days after birth [43], it
becomes demanding to unravel TJ-independent cld7 ac-
tivities. We approached the question of cld7 localization
using easily transfectable HEK cells to generate a tool of
cells stably expressing wt or mutated cld7 and/or EpC.
Whereas single serine to alanine mutations was ineffect-
ive, a palmitoylation site mutation was accompanied by a
striking shift in the membrane subdomain localization.
Thus, we focused on palmitoylation defective cld7 and on
mutated EpC that cannot bind cld7 [61]. The latter
allowed differentiating between genuine cld7 activities and
those requiring the association with EpC.
Cld7 palmitoylation and tight junctions
In advance of discussing the impact of cld7 palmitoyla-
tion on membrane subdomain localization, it should be
remembered that mutating AA184 and AA186 efficiently
prevented cld7 palmitoylation and that palmitoylation at
the C-terminal tail appears to be dominating, because
only a very faint palmitoylation signal was detected in
HEK-EpC-cld7mPalm. The high efficacy of cld7mPalm relo-
calization and striking differences in associating molecules
are in line with the dominance of the C-terminal tail cld7
palmitoylation.
Figure 7 Palmitoylated claudin-7 supports the generation of EpIC (a) Confocal microscopy of HEK-EpC-cld7 and HEK-EpC-cld7mPalm cells stained
with anti-EpIC and -cld7; single fluorescence staining and overlays are shown (scale bar: 10 μm) and WB of lysates of PMA-stimulated transfected
HEK cells with anti-EpIC; EpIC and EpC bands are indicated. (b) Confocal microscopy of HEK-EpC-cld7 and HEK-EpC-cld7mPalm cells stained with
anti-presenilin2 and -cld7 (single fluorescence and overlays, scale bar: 10 μm); sucrose gradient fractions of lysates of PMA-stimulated HEK-EpC-cld7,
HEK-EpCmAG-cld7 and HEK-EpC-cld7mPalm cells were immunoprecipitated with anti-presenilin2, precipitates were blotted with anti-EpC, anti-cld7 and
anti-presenilin2. (c) WB of presenilin2 and β-catenin in PMA-stimulated transfected HEK cells. (d) Flow cytometry analysis of mesenchymal proteins in
PMA-stimulated transfected HEK cells; the mean fluorescence index (% stained cells x mean intensity of staining ± SD; three assays) and representative
examples are shown (mean % stained ± SD, mean intensity ± SD; triplicates and representative examples); significant differences between HEK-cld7
versus HEK-EpC-cld7, HEK-EpCmAG-cld7 and HEK-EpC-cld7mPalm cells: *. (e) Representative examples of FGF, vimentin and N-cadherin co-localization
with cld7 (confocal microscopy, scale bar: 10 μm). Palmitoylated cld7 facilitates the generation of EpIC by associating with presenilin-2 in GEM. EpIC
generation is accompanied by a slight upregulation of mesenchymal protein expression.
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Palmitoylated cld7 is enriched in GEM, but is not
recovered in TJ protein complexes. Cld7 poorly colo-
calizes and co-immunoprecipitates with cld3, cld4 and
ZO-1, which strikingly differs from colocalization and
co-immunoprecipitation of ZO-1 with cld3 and cld4.
Instead, palmitoylation-deficient cld7 associates with
TJ proteins. We have not explored, whether overex-
pression of cld7mPalm in HEK cells suffices establishing
classical TJ, as was described for a cld7 overexpressing
epithelial like cell line [62]. However, HEK-EpC-
cld7mPalm cells do not form tightly packed monolayers
like epithelial cells and trogocytosis of membrane fractions
from biotinylated HEK-EpC-cld7mPalm by non-biotinylated
HEK-EpC-cld7mPalm was not in support of “kissing points”
(data not shown). On the other hand, only palmitoylated
cld7 associates with EpC.
Palmitoylation supports anchoring in GEM [16,17].
GEM microdomains are signaling platforms facilitating
attachment of cytoplasmic kinases [16,18,19]. GEM also
are prone for internalization [21-24]. This is a sequel of
the attachment of complexes that promote scission,
fission and early endosome traffic towards multivesicular
bodies, where proteins become ubiquitinated and degraded
in the proteasome [63]. Alternatively, the multivesicular
bodies are transported back to the plasma membrane and
the intraluminal vesicles are released as exosomes [64].
Notably, claudins were recovered in internal vesicles colo-
calizing with syntaxin4 [65], but did not reintegrate into TJ.
Syntaxin4 being one of the components for vesicular
transport [66], we suggest an independent route of
trafficking of TJ- versus GEM-integrated claudins. In fact,
colon carcinoma lines secrete two populations of exo-
somes, only exosomes from the basolateral region contain
the EpC-cld7 complex [59]. Furthermore, the association
with EpC hampers the integration of cld7 and via cld7 the
integration of cld1 into TJ [60].
Figure 8 Palmitoylated claudin-7 and invasion (a) HEK cells were seeded in matrigel-coated transwell plates, matrigel invasion (recovery within
the matrigel) and penetration (recovery at the lower site of the insert) was evaluated after 16 h; mean number ± SD (triplicates) of invading
and penetrating cells and representative examples (scale bar: 250 μm); significant differences between HEK-EpC-cld7 and HEK-EpCmAG-cld7 or
HEK-EpC-cld7mPalm: *. (b) Flow cytometry of MMP and CD147 expression in untransfected and transfected HEK cells; the mean fluorescence
index (% stained cells x mean intensity of staining ± SD; three assays) and representative examples are shown; significant differences in transfected
versus non-transfected HEK cells: *. (c) Confocal microscopy of transfected HEK cells stained with anti-cld7 and anti-MMP3 or -MMP14; single
fluorescence and overlays of representative examples (scale bar: 10 μm). Despite slight downregulation of MMP3, MMP7 and MMP9 by cld7,
palmitoylated cld7 promotes invasiveness.
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Palmitoylation-deficiency of cld7 had significant
bearing on associating molecules and their activation
state. A strikingly reduced number of proteins co-
immunoprecipitated with cld7 in lysates of HEK-EpC-
cld7mPalm and phosphorylation of co-immunoprecipitating
proteins was additionally impaired. The number of mole-
cules co-immunoprecipitating with anti-cld7 from HEK-
EpCmAG-cld7 lysates was also reduced, though the reduc-
tion was less pronounced. These findings indirectly con-
firm the direct association of EpC with cld7 [35] and
support a dominating role of palmitoylation-competent
cld7 in associated molecule activation. It is particularly
worthwhile noting that only palmitoylation-competent
cld7 abundantly associates with vesicular transport mole-
cules. It remains to be explored, whether this translates
into a central role of cld7 in exosome composition and
release.
Taken together, the membrane subdomain localization
of cld7 is dictated by palmitoylation. This has most se-
vere consequences on associating molecules and their
activation state. Building on this, we asked for functional
consequences.
Palmitoylated claudin-7 prohibits adhesion and supports
motility
The striking impact of cld7 palmitoylation on the redistri-
bution into GEM and on the association with (phosphory-
lated) GEM-located molecules suggests that palmitoylated
cld7 fulfills TJ-independent activities. We had described
that tetramer formation and homophilic EpC binding [67]
Figure 9 Palmitoylated claudin-7, MMP activity and CD147 (a) Zymography of HEK, HEK-EpC, HEK-cld7, HEK-EpC-cld7 and HEK-EpCmAG-cld7
or HEK-EpC-cld7mPalm supernatants. (b) HEK cells were seeded in matrigel-coated transwell plates in the presence of anti-CD147 (10 μg / ml)
(a representative example is included in Figure 8a); invasion and penetration was evaluated as above; significant inhibition by anti-CD147: s. (c)
Confocal microscopy of HEK-cld7, HEK-EpC-cld7 and HEK-EpCmAG-cld7 or HEK-EpC-cld7mPalm cells stained with anti-cld7 and anti-CD147 (single
fluorescence and overlays, scale bar: 10 μm). (d) HEK-cld7, HEK-EpC-cld7, HEK-EpCmAG-cld7 and HEK-EpC-cld7mPalm lysates were precipitated with
control IgG or anti-CD147; after SDS-PAGE and transfer precipitates were blotted with anti-EpC, anti-cld7 and anti-CD147. Palmitoylated cld7-promoted
invasiveness likely is supported by associated MMP14 and CD147, which can strengthen MMP2 and MMP9 activation and expression.
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is distorted by the association with cld7 [56]. We now re-
ported that the cld7-mediated inhibition of homophilic
EpC binding depends on cld7 palmitoylation and the
GEM localization. The elegant study by Wu et al. [60] also
reported that EpC interferes with the integration of cld1
and cld7 in TJ and supports recruitment into vesicles.
These findings are in line with our observations, which
suggest that cld7 palmitoylation is the prime cause,
followed by the association with EpC. GEM-located TACE
[68], which cuts transmembrane molecules in membrane
proximal regions [69], supports the interference of cld7
with homophilic EpC binding by the liberation of EpEx.
Thus, palmitoylated cld7 inhibits EpC-mediated cell-cell
adhesion by prohibiting tetramer formation and by pro-
moting EpEx liberation.
Palmitoylated cld7 also actively supports cell motility
that is accompanied by organization of the disordered
actin cytoskeleton in HEK cells [57]. GEM-located, pal-
mitoylated cld7 associates with CD166 and α5, the latter
being the most abundantly expressed integrin in HEK
cells [57]. The cld7 colocalization with α5 and CD166 in
GEM suffices for src, FAK and paxillin association and
phosphorylation. Importantly, palmitoylated cld7 associ-
ates with phosphorylated ezrin, which can explain the
striking consequences on HEK cell motility and actin
cytoskeleton organization. As outlined above, cld7 also
cooperates with TACE, which also cleaves the cell-
matrix adhesion molecule CD166 [39,70,71]. It remains
to be explored, whether cleavage of CD166 indirectly
supports motility by breaking adhesive cell contacts.
Palmitoylated cld7 additionally contributes to motility by
facilitating EpIC generation. By a change in conformation
after EpEx cleavage, presenilin2 can bind and liberate the
cotranscription factor EpIC [39]. Though EpIC generation
may not essentially depend on cld7 coexpression [39], EpC
recruitment into GEM via palmitoylated cld7 strengthens
the efficacy of EpIC generation, which is accompanied by
increased expression of the mesenchymal proteins FGF,
TGFβ and N-cadherin. The shift towards mesenchymal
protein expression could strengthen motility.
Though the association of palmitoylated cld7 with
EpC does not suffice for a full-fledged shift towards
EMT, our findings are quite distinct from a recent publi-
cation on cld7-induced MET, which is accompanied by
rab25 upregulation [72]. Rab25 can be a tumor suppres-
sor in colon cancer [73], but promotes tumor growth in
several different cancer types [74]. Interestingly, in hor-
mone receptor negative breast cancer rab25 expression
is very low, but the small subpopulation of cancer initiat-
ing cells express rab25 [75]. Based on this finding, we sug-
gest that palmitoylated cld7 and the vesicle transporter
rab25 support cancer-initiating cell activities, possibly via
the transfer of exosomes. Our suggestion is in line with
the central importance of rab molecules in vesicle traffic
and exosome release [76], the delivery of cld7-EpC com-
plex expressing exosomes by colorectal cancer cells and
the abundant association of vesicle traffic-associated mol-
ecules with palmitoylation-competent cld7.
Despite the need to experimentally support the latter
hypothesis, our data demonstrate an active contribution
of palmitoylated cld7 to cell motility, which is based on
the GEM-location-dependent association with EpC, integ-
rins, CD166, cytoskeletal linker and signaling molecules.
Claudin7 and proteases
Cld7 can repress MMP3 [43], which could hamper inva-
siveness. Opposing our expectation, HEK-cld7 cells are
strongly invasive. HEK cells express MMP3 and MMP7
at an intermediate level. Independent of cld7 palmitoyla-
tion, both proteases are slightly downregulated in HEK-
cld7 cells. Cld7 expression did not affect expression of
other MMPs in HEK cells. On the other hand, gelatino-
lytic activity of HEK-cld7 cells was increased. Palmitoy-
lated cld7 colocalizes with MMP14, which supports
retention of MMP2 and MMP9 close to the plasma mem-
brane. Furthermore, HEK cells highly express CD147 that
stimulates MMP expression in neighboring cells [77,78].
CD147 colocalizes and co-immunoprecipitates with
palmitoylated cld7 and thereby can contribute to cld7-
promoted invasiveness. This interpretation is supported
by the finding that anti-CD147 strongly inhibits HEK-cld7
and HEK-EpC-cld7, but not weak HEK-EpC-cld7mPalm cell
invasion.
Taken together, in HEK cells a repression of MMP3 by
cld7 has no bearing on invasiveness, as palmitoylated cld7
supports invasion by associating with MMP14 and CD147.
Conclusions
The (patho)physiological relevance of the EpC-cld7 com-
plex was demonstrated repeatedly, most convincing by
the death of EpCko mice [41,42], by the shift of cld1 and
cld7 towards TJ in EpCkd cells [60], by the pronounced
recovery of GEM-located cld7-EpC-CD44v6-Tspan8 com-
plexes in colorectal cancer [36,52] and by the metastasis-
supporting activity of the EpC-cld7 complex in pancreatic
and colorectal cancer [35,36,38,52,61]. We here demon-
strated that under physiological conditions, i.e. without
chemical or antibody crosslinking, a considerable part of
cld7 is palmitoylated and that palmitoylation drives cld7
into GEM, but prohibits integration into TJ. In GEM,
palmitoylated cld7 associates with adhesion molecules,
proteases, cytoskeletal linker and signal transduction mol-
ecules, which supports motility and invasion. Though the
reason for the preferential palmitoylation state of cld7
remains to be explored, palmitoylated cld7 exhibits TJ
opposing activities, which should be taken into account
considering the role of cld7 in development and
metastasis.
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Material and methods
Cell lines and transfectants
HEK293 cells [79] cells were transfected with rat EpC
cDNA and cotransfected with rat cld7 cDNA using the
pcDNA3.1 vector that carries either the neomycin or the
hygromycin resistance cDNA. Where indicated, the cld7
cDNA was mutated at the serine residues AA33, AA69,
AA87, AA172, AA204, AA206 and AA207, exchanging
serine by alanine (HEK-EpC-cld7mSxx) and with cld7
cDNA, where the palmitoylation site was destroyed by
mutations at AA184 and AA186 (HEK-EpC-cld7mPalm).
The EpC cDNA was mutated at AA279 and AA282,
which are located in the transmembrane region and ac-
count for the EpC-cld7 association (HEK-EpCmAG-cld7)
(Additional file 1) and cDNA inserts were sequenced.
Cells were transfected with lipofectamin and cultured in
RPMI/10% FCS plus 500 μg/ml G418 and/or 150 μg/ml
hygromycin. Transfection efficacy, evaluated by WB and
flow cytometry, ranged between >90% to 98%.
Antibodies and chemicals
Additional file 5.
Sucrose density gradient centrifugation
Cell lysates in 2.5 M sucrose were overlaid by a continu-
ous sucrose gradient (0.25 M-2 M) and centrifuged
(15 h, 150000 g) and twelve 1 ml fractions were
collected. Proteins located in GEM are recovered in
fractions 2–4.
In vitro kinase assay
Immune complexes were suspended in lysis buffer con-
taining a protease inhibitor mix. After centrifugation,
beads were resuspended in 30 μl kinase assay buffer,
10 μCi [32P]γ-ATP and incubated (15 min, 37°C), stop-
ping the reaction by 10 μl non-reducing 6x Laemmli
buffer. SDS-PAGE was followed by autoradiography.
IP, Western blot (WB)
Lysates (30 min, 4°C, HEPES buffer, 1% Lubrol or 1%
TritonX-100, 1 mM PMSF, 1 mM NaVO4, 10 mM NaF,
protease inhibitor mix) were centrifuged (13000 g,
10 min, 4°C), mixed with antibody (1 h, 4°C) and incu-
bated with ProteinG-Sepharose (1 h). For the analysis of
released EpEx (EpC extracellular domain), culture super-
natant were depleted of exosomes [80]; supernatant were
10-times concentrated. Washed complexes/lysates, dis-
solved in Laemmli buffer, were resolved in 10%-12%
SDS-PAGE. For the recovery of EpIC, Tris-Tricine and
16% SDS-PAGE was used under non-reducing condition.
After protein transfer, blocking, blotting with antibodies,
blots were developed with ECL.
Palmitoylation assay
Palmitoylation of cld7 was determined using the IP-ABE
method [81]. In brief, cultured cells were lysed in the
presence of N-ethylmaliemide (NEM), using lysis buffer
(LB) (50 mM NEM, 1% Triton-X-100, 1x protease in-
hibitor cocktail, 1 mM phenylmethanesulfonylfluoride
(PMSF)) for irreversibly blocking unmodified thiol groups.
After an IP with anti-cld7, G-Sepharose coupled precipi-
tates where incubated with hydroxylamine (HAM) buffer
(1 h, room temperature, LB pH7.2, 1 M HAM) for specific
cleavage and unmasking of the palmitoylated cysteine
thiol group. Thereafter samples were incubated in biotin-
BMCC buffer (LB pH 6.2, 1 μM biotin-BMCC, 1 h, 4°C)
for selective labeling of the palmitoylated cysteines. Sam-
ples were eluted in LB pH7.5 followed by SDS-PAGE and
WB with streptavidin-HRP.
MALDI-TOF analysis
After SDS-PAGE, gels were stained. Protein digestion,
sample preparation, MALDI-TOF fingerprint analysis,
post-source decay fragmentation analysis and database
searches were performed as described [82].
Flow-cytometry
Flow-cytometry followed routine procedures. In brief,
1–2.5×105 cells were seeded in 96-well plates. After wash-
ing with PBS/1% BSA, cells were incubated with the pri-
mary antibody (2–10 μg/ml, 40 μl, 30 min, 4°C). Cells were
washed 3-times with PBS/1% BSA and incubated with a
secondary dye-labeled antibody at predetermined concen-
tration. Negative controls were only incubated with the sec-
ondary dye-labeled antibody (40 μl, 30 min, 4°C). For
intracellular staining, cells were fixed (PBS/1% formalde-
hyde, 30 min, 4°C) and permeabilized (PBS/0.5% Tween-20,
20 min, 4°C). Samples were processed in a FACS-Calibur
and evaluated with the CellQuest program. Data are pre-
sented as a weighted score, the fluorescence index (FI)
representing the percentage stained cells × the mean fluor-
escence intensity above background.
ELISA
For the recovery of EpEx, cells were cultured in serum-
free medium for 48 h. Supernatants were centrifuged,
concentrated and adjusted to 100 μg/ml, evaluating the
amount of EpEx by a direct ELISA coating the wells with
culture supernatant and proceeding with a standard
protocol using anti-rat EpC (D5.7) for detection.
Confocal microscopy
Cells on glass-slides were fixed (4% paraformaldehyde, 20 min
on ice), permeabilized (1% Triton-X100, 4 min, on ice),
blocked (PBS/1% gelatin, 30 min, on ice), incubated with pri-
mary antibody (60 min, on ice), washed, incubated with
fluorochrome-conjugated secondary antibody (60 min,
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on ice), blocked (IgG with irrelevant specificity of the
same species as the primary antibody), incubated with a
second, dye-labeled primary antibody and washed.
Slides were mounted in Elvanol. Digitized images were
generated using a Leica LMS780 microscope and the
Carl Zeiss Vision software for evaluation. The Z-stack
offers 30 positions through the depth of the cell. All pic-
tures were taken at Z-stack 14–16. Depending on the
quality of the antibody and the density of marker
expression, the intensity for the green channel varied
between 700–900 master gain values and for the red
channel between 500–750 master gain values. The
photosystem automatically generates the single fluores-
cence and overlay pictures.
Cell adhesion
CFSE-labeled cells were seeded on a cell monolayer in
96-well plates. After washing, adherent cells were lysed,
evaluating fluorescence intensity photometrically. Adhe-
sion is presented as percent seeded cells.
Migration
Cells, in the upper part of a Boyden chamber (RPMI /
0.1% BSA), were separated from the lower part (RPMI /
20% FCS) by 8 μm pore size polycarbonate-membranes.
After 16 h, the lower membrane side was stained (crys-
tal-violet), measuring OD595 after lysis. Migration is
presented as percentage input cells. In an in vitro wound
healing assay, a subconfluent monolayer was scratched
with a pipette tip. Wound closure was controlled by light
microscopy. For videomicroscopy, cells (5×104) were
seeded on matrix protein-coated 24-well plates. Plates
were placed under an Olympus IX81 inverse microscope
with an Hg/Xe lamp, an incubation chamber (37°C, 5%
CO2), a CCD camera (Hamamatsu) and a ScanR acquisi-
tion soft ware (Olympus, Hamburg, Germany). Two pic-
tures (20-fold magnification)/chamber (2 ms exposure)
were taken every 20 min for 12 h. Migration was quanti-
fied according to Manual_tracking plugin running in the
open-source software Image J.
Statistics
All experiments were repeated at least 3 times. Mean values
of triplicates or for videomicroscopy of 20 individual cells
or of, at least 3 independent experiments are presented.
Significance was evaluated by the two tailed Student’s t-test.
P-values <0.05 were considered significant.
Additional files
Additional file 1: Primers.
Additional file 2: The impact of cld7 serines on membrane
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